Chapter 14. An Engineered Human Antibody for Chronic Therapy: CDP571

  1. Prof. Dr. H.-J. Rehm2 and
  2. Dr. G. Reed3
  1. Mark Sopwith and
  2. Sue Stephens

Published Online: 7 MAY 2008

DOI: 10.1002/9783527620999.ch14d

Biotechnology Set, Second Edition

Biotechnology Set, Second Edition

How to Cite

Sopwith, M. and Stephens, S. (2001) An Engineered Human Antibody for Chronic Therapy: CDP571, in Biotechnology Set, Second Edition (eds H.-J. Rehm and G. Reed), Wiley-VCH Verlag GmbH, Weinheim, Germany. doi: 10.1002/9783527620999.ch14d

Editor Information

  1. 2

    Institut für Mikrobiologie, Universität Münster, Corrensstraße 3, D-4400 Münster

  2. 3

    2131 N. Summit Ave., Apartment #304, Milwaukee, WI 53202-1347, USA

Author Information

  1. Slough, UK

Publication History

  1. Published Online: 7 MAY 2008
  2. Published Print: 10 MAY 2001

ISBN Information

Print ISBN: 9783527257621

Online ISBN: 9783527620999

SEARCH

Keywords:

  • dysfunction;
  • destruction;
  • exacerbations;
  • proliferation;
  • neutralizing

Summary

The prelims comprise:

  • Introduction

  • Generation of Engineered Human Antibody, CDP571

  • Preclinical Studies with CDP571 in Non-Human Primates

  • Studies with CDP571 in Humans

  • Conclusions